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Peritoneal dialysis adequacy: A model to assess feasibility with weekly normalized urea clearance (Kprt/V) of 2.0 or
various modalities. more and a creatinine clearance (CCr) of 60 liter/1.73 m2
Background. The current standard of adequacy for perito- or more [3]. Recognized weaknesses of these guidelinesneal dialysis (PD) is to provide a weekly normalized urea
include: (a) the lack of evidence to establish equivalencyclearance (Kt/V) of 2.0 or more and a creatinine clearance
between the renal and peritoneal contributions of small(CCr) of 60 liter/1.73 m2 or more. As native renal function is lost,
it is important to determine the effectiveness of the available solute removal to clinical outcome; and (b) the uncertain
therapeutic modalities in achieving these goals. value of urea versus creatinine as markers of uremia
Methods. A model to assess our ability to provide a weekly [4, 5]. Most clinical outcome studies have included pa-Kt/Vurea of 2.0 or more and a CCr of 60 liter/1.73 m2 or more tients at various stages of uremia therapy with differentto anuric patients undergoing continuous ambulatory PD
degrees of residual renal function (RRF). The most(CAPD) and automated PD (PD Plus) was developed. The
body surface area (BSA) distribution was obtained from 38,768 quoted prospective study, CANUSA, was not designed
patients undergoing dialysis during January 1997. The distribu- to evaluate the relative effect of RRF and the peritoneal
tion of peritoneal transport rates (PTRs) was obtained from clearance on patient outcome [2, 6, 7]. Furthermore,2531 peritoneal equilibration tests performed during 1996. The
patients with significant RRF are more likely to achieveweekly Kpt/Vurea was calculated for the various PTR groups
higher clearances of creatinine than anuric patients be-and the range of BSA with four PD prescriptions: CAPD 8
liters, CAPD 10 liters, PD Plus 12 liters, and PD Plus 15 liters, cause of tubular secretion of creatinine in advanced renal
using a previously validated kinetic program (PackPD). failure. Few prospective studies have been performed in
Results. The predicted percentage of patients capable of
anuric patients undergoing PD. However, Selgas et alachieving the adequacy goals for Kt/V and CCr, respectively,
studied patients who had a minimum of three years onwere 24.8 and 11.2 for CAPD 8 liters, 54.2 and 33.0 for CAPD
10 liters, 77.8 and 54.9 for PD Plus 12 liters, and 93.2 and 72.9 PD and who were mostly anuric [4]. They observed an
for PD Plus 15 liters. excellent correlation between Kt/Vurea and survival, but
Conclusions. Most patients can attain the current adequacy failed to establish a correlation between CCr and outcome.standards of therapy with automated PD, but few (less than
As RRF is lost, the dose of PD must be necessarily25%) can do so with standard CAPD in the absence of residual
adjusted in most patients undergoing continuous ambu-renal function.
latory PD (CAPD) and many undergoing automated PD
(APD) in order to satisfy the adequacy criteria. The
proportion of patients capable of achieving the afore-New standards for peritoneal dialysis (PD) adequacy
mentioned goals of PD adequacy in the absence of RRFhave been recently proposed based on theoretical con-
has not been established. Theoretical models have con-structs and clinical outcome studies [1–3]. These recom-
sidered the patients peritoneal transport rates (PTRs),mendations are to provide a total (peritoneal and renal)
body size, and dialysis prescription and have either disre-
garded ultrafiltration or modeled it from their peritonealKey words: kinetic modeling, continuous ambulatory peritoneal dial-
equilibration tests (PETs) [8–10]. However, they lackedysis, automated peritoneal dialysis, urea clearance, creatinine clear-
ance, residual renal function. statistical information on the distribution of patient size,
distribution of PTRs, or actual solute removal with spe-Received for publication September 9, 1998
cific PD modalities.and in revised form January 11, 1999
Accepted for publication January 12, 1999 This study assesses the feasibility of achieving PD ade-
quacy with various therapeutic modalities by using statis- 1999 by the International Society of Nephrology
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METHODS
In order to develop a model to assess the proportion
of anuric patients capable of achieving a weekly Kpt/V
of 2.0 or more or a CCr of 60 liter/1.73 m2 or more, the
following information is required concerning the popula-
tion to be studied: (a) the distribution of patient size, (b)
the distribution of PTRs, and (c) the clearances obtained
with various prescriptions in patients with different body
size and PTRs.
Determination of patient size distribution
The records of all patients undergoing hemodialysis
(HD) three times weekly on the consecutive Monday
and Tuesday of the third week of January 1997, and of
all PD patients seen for their monthly visit during the
same month in all Fresenius Medical Care North Amer-
ica facilities were used to determine gender, height (cm),
and weight (kg). For HD patients, the postdialysis weight
was used. For PD patients, the weight used was the
only one recorded for that visit; however, there was not
sufficient information to determine whether the patients
were weighed during dialysis or after a full drain. Body
surface area (BSA) was calculated using du Bois and du
Bois formula in 35,103 HD and 3665 PD patients with
complete records [11]. Distribution histograms were gen-
erated for each population from these data.
Determination of peritoneal transport rate distribution
The distribution of PTR was based on data from PETs
performed at LifeChem Laboratories (Rockleigh, NJ,
USA) between January 1, 1996, and December 31, 1996,
on 2531 patients. Standard methodology was used for
four-hour PET determinations [12]. Only complete stud-
ies with data at times 0, 2, and 4 hours were included.
Dialysate creatinine values were corrected for glucose
concentration [12, 13]. Plasma concentrations for ureaFig. 1. Distribution of body surface area (BSA) for (A) hemodialysis,
(B) peritoneal dialysis, and (C) a combined group of dialysis patients. and creatinine were used. The PTR classification was
based on four-hour dialysate to plasma ratios (D/P4 hr)
for creatinine as described by Twardowski et al [12].
Four groups of PTR were defined as follows: low, forTable 1. Classification of peritoneal transport groups
values between 1% and mean –1 sd; low-average, be-
Group D/PCr4hr D4D0 tween mean and mean –1 sd; high-average, between
Low ,0.53 .0.56 mean and mean 11 sd; and high, between mean 11 sd
Low-average 0.67–0.54 0.44–0.55 and 99%.High-average 0.67–0.80 0.44–0.33
High .0.81 ,0.32
Definition of peritoneal dialysis modalities
and prescriptions
Four PD prescriptions were used for modeling using
various total dialysis solution volumes. Two prescriptionstical information for patient size and peritoneal transport
used manual CAPD and two used a hybrid APD-CAPDgenerated during a recent period of time with a large
modality known as PD Plus [14]. PD Plus consists ofnumber of patients who were considered representative
three to five automated cycles at night that are deliveredof the United States PD end-stage renal disease (ESRD)
population and kinetic modeling using a validated pro- by a simple peritoneal cycler and use high exchange
volumes (Vip) in the range of 2.5 to 4.0 liters. The firstgram.
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Table 2. Definition of peritoneal transport curves
Peritoneal transport group
Prescription Low Low-average High-average High
CAPD-8 y543.384x20.993 y554.015x20.989 y558.191x20.992 y561.012x20.987
CAPD-10 y553.445x20.994 y567.069x21.000 y580.173x21.030 y576.452x20.997
PD112 y563.628x20.995 y574.826x20.989 y580.898x20.994 y590.018x21.000
PD115 y576.208x21.007 y591.311x21.001 y596.807x20.998 y5110.514x21.000
Fig. 2. Relationship between weekly Kpt/Vurea and volume of distribution of urea (Vsa) according to four different peritoneal dialysis prescriptions
and peritoneal transport rates. Symbols are: (–) PD Plus-15; (d) PD Plus-12; (1) CAPD-10; (•) CAPD-8.
diurnal exchange is the last exchange delivered by the The four prescriptions used were as follows: CAPD
with four 2-liter exchanges (CAPD-8); CAPD with fourcycler in the morning. An additional manual exchange
is provided at midday to avoid prolonged dwell times in 2.5-liter exchanges (CAPD-10); PD Plus using three
3-liter exchanges at night and two, 1.5-liter exchangesexcess of seven hours. The diurnal Vip varies between
1.5 and 2.0 liters for most adult patients. during the day (PD Plus-12); and PD Plus using four
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insufficient values. Data from actual CCr determinations
from 188 patients representing the four PTR groups and
who were undergoing PD with one of the four different
prescriptions were used instead. The CCr values reported
were normalized to BSA (liter/1.73 m2).
Assessment of feasibility of achieving adequacy
The maximum Vsa that can be successfully treated
must be determined from an appropriate solution of
equation 1 for Kt/Vurea 5 2.1 for each transport category
and each therapy. The power function in equation 1 is
converted to exponential form in accordance with
2.1 5 a * exp(lnVsa * b) (Eq. 2)
The solution for equation 2 for Vsa is
Fig. 3. Relationship between weekly CCr and peritoneal transport rates
Vsa 5 exp [ln (2.1/a)/b] (Eq. 3)for four different prescriptions. The figures in parenthesis denote the
number of patients studied. A description of the dialysis prescriptions
Thus, with equation 3, we can compute maximum Vsais in the text. Symbols are: (d) CAPD-8; (d) CAPD-10; (.) PD
Plus-12; (,) PD Plus-15. at which Kt/Vurea 5 2.1 for each transport category and
each therapy.
When we know the maximum Vsa for which a Kt/Vurea
of 2.1 can be achieved for each of the four transport2.75-liter exchanges at night and two 2.0-liter exchanges
groups with each of the four therapies, we can calculateduring the day (PD Plus-15).
the maximum BSA for which Kt/Vurea of 2.1 can beAll prescriptions were modeled using dialysis solutions
achieved by solving the Hume equations for BSA withwith 2.5% glucose.
known Vsa [17]. These solutions are:
Determination of clearance with BSA 5 (Vsa 1 8.46)/25.47 for male patients
different prescriptions (Eq. 4)
A family of kinetic curves was computed for each of
BSA 5 (Vsa 1 7.73)/22.72 for female patientsthe four transport categories (low, low average, high
(Eq. 5)average, and high). The therapies modeled for each
transport category were CAPD-8, CAPD-10, PD Plus-12, The frequency distribution of the four PTR groups
and PD Plus-15. The PackPD kinetic modeling program, (fPTR) in the population is known. We also know the
which was previously validated [15, 16], was used with cumulative frequency distribution of BSA (fBSA) in the
pt50urea values corresponding to the transport categories population so that from the maximal treatable Vsa calcu-
to compute weekly Kt/Vurea for all four therapies as a lated, the maximal treatable BSA for each PTR and
function of body water [noted below as volume flow (V) therapy can be computed, and from the cumulative fre-
calculated from BSA or volume of distribution of urea quency distribution of BSA, we can compute the fraction
(Vsa)]. The pt50urea value is the dwell time required for of the total population for which Kt/Vurea or CCr/1.73 m2the study solute concentration in the peritoneal solution
target can be reached with each therapy. The fractionto equal 50% of the plasma concentration. Values for
of the total patient population (fTpop) in each PTRKt/Vurea were computed with the modeling program for group treatable with each therapy is then calculated fromeach transport category and each therapy with Vsa vary-
the product:ing from 20 to 60 liters. The results (Fig. 2) were found
to be best expressed as power functions (Table 2) of the fTpop 5 (fPTR) (fBSA)
general formula:
The results of these calculations were expressed as aKt/Vurea 5 a (Vsa)b (Eq. 1)
percentage.
where Vsa is expressed in liters. A target weekly pre- For example, the percentage of male patients achieving
scribed Kpt/Vurea of 2.1 was plotted on each therapy curve adequacy (weekly Kpt/V of 2.1 or more) with CAPD-10
to demonstrate the maximum patient Vsa possible to and who are high-average transporters is determined as
attain the prescribed level of therapy. follows:
The determination of weekly CCr for the various PTR
groups was not possible using the pooled data because of Kt/V 5 80.173 (Vsa)21.030
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Fig. 4. Predicted weekly Kpt/V for a male
patient with a BSA 5 1.73 m2 and a Vsa 5
35.6 liters according to peritoneal transport
rate and prescription. The values over each
bar denote Kpt/V for the specific PTR and
prescription. Symbols are: (h) low; ( ) low-
average; ( ) high-average; (j) high.
Fig. 5. Predicted maximum body surface area (BSA) for males and females undergoing different prescriptions according to peritoneal transport
rate in order to achieve a Kpt/V of 2.1 or more. Values above the bars denote the BSA for the specific PTR, prescription, and gender. Abbreviations
are: L, low; LA, low-average; HA, high-average; H, high; M, male; and F, female. Symbols are: ( ) L-M; ( ) L-F; ( ) LA-M; ( ) LA-F; ( )
HA-M; ( ) HA-F; (h) H-M; (j) H-F.
By using equation 3, BSA 5 (34.33 1 8.46)/25.47 5 1.68 m2
or the maximum BSA for a male patient with high-Vsa 5 exp [ln (2.1/80.173)/(–1.03)]
average transport undergoing CAPD-10 while achieving
Vsa 5 exp [–36422/–1.030] 5 34.33 liters a Kt/Vurea of 2.1.
The fraction of the total patient population in theFrom equation 4, the BSA from the Vsa for male patients
high-average PTR (FPTR) is 35.1%, and the cumulativecan be calculated as follows:
frequency distribution of a BSA of 1.68 m2 or less (fBSA)
is 51.8%. Therefore, applying equation 6, the fraction ofBSA 5 (Vsa 1 8.46)/25.47
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the total male population with high-average transport DISCUSSION
that can achieve a Kt/Vurea of 2.1 or less is calculated as: This study is based on kinetic modeling using a vali-
dated program and using the actual PTRs and body sizefTpop 5 (fPTR) (fBSA)
distribution from a large cross-sectional sample of pa-
fTpop 5 (0.351) (0.518) 5 0.182 or 18.2% tients. The modeling was performed assuming no contri-
bution from RRF. The model nonetheless assumes pa-
tient compliance and the optimal prescription for the
RESULTS specific modality of therapy.
The distribution of BSA for patients undergoing HD Patient size, based on BSA, is probably the same for
and PD is shown in Figure 1. The mean BSA for HD the PD and HD population. The slightly higher values
was 1.74 m2. For PD, it was 1.80 m2, and for the combined observed for PD patients could be explained by the
population, it was 1.75 m2. The gender distribution was higher weights of the PD patients resulting from the
similar for both groups, with 51% males among HD and dialysate carried by some patients. Our results would
49% among PD patients. not be significantly affected by using patient size based
Peritoneal transport groups are defined in Table 1, on the PD populations, the HD population, or the com-
and the peritoneal transport curves are defined in Table bined results (used in this study) because the difference
2. Based on the D/PCr at four hours, 14.1, 34.3, 35.1, and in BSA was very small at 0.06 m2, and the BSA distribu-
16.4% of the patients fell into the low, low-average, tion histograms categorized patients by 0.10 m2.
high-average, and high categories, respectively. Figure 2 A possible source of error is the derivation of Vsa
summarizes the weekly Ktp/V modeled from the from the Hume equation rather than from the Watson
PackPD data pool by patient size (Vsa) and dialysis model [18], which considers age and sex, in addition to
prescription for each PTR group. The mathematical weight and height. These methods of calculating volume
definition of the various peritoneal transport curves is of distribution of urea generally agree well; however,
provided in Table 2. A consistent upward shift of the they may differ by as much as 10%. When these methods
curves is observed for every increase in PTR. Figure 3 differ, it is often not clear which is more accurate.
plots CCr obtained with different prescriptions in patients The PTR distribution is, by definition, quasi-normal,
with different PTRs. and the categories are very similar to those reported by
Figure 4 shows the Kpt/V predicted for a male patient Twardowski et al in a much smaller sample of patients,
with a BSA 5 1.73 m2 and a Vsa 5 35.6 l according to particularly for D/PCr [12].
PD modality and for different PTRs. Figure 5 illustrates The model predicts that the great majority of patients
the predicted maximum BSA for males and females un- (more than 90%) can achieve adequacy levels for
dergoing PD with different modalities and with various Kt/Vurea in the absence of RRF and that most patientsPTRs in order to achieve a weekly Kpt/V of 2.1 or more. (more than 70%) can also satisfy the CCr criterion withThe BSA is consistently higher for females for the same
the available therapeutic armamentarium. The large
PTR group and prescription because of their lower Vsa
variation noted in the curves describing CCr among highrelative to males with the same BSA.
transporters undergoing PD Plus may reflect the limitedThe percentage of patients capable of achieving a
number of observations. It is important to stress thatweekly Kpt/V of 2.1 or more with the various prescrip-
only a small proportion of the ESRD population can betions and PTRs are provided for males (Fig. 6), females
adequately dialyzed with standard CAPD in the absence(Fig. 7), and all patients (Fig. 8). Standard CAPD-8 only
of RRF, regardless of the criterion of adequacy used.satisfied the adequacy criterion in 24.8% of cases, whereas
Although CAPD is an important and very commonlyPD Plus-15 achieved the goal in 93.2% for the combined
used form of therapy for the initiation of dialysis, fre-group of all patients.
quent monitoring of RRF and adjustments in dialysisThe percentage of patients able to achieve a weekly
dose are needed to maintain adequacy.CCr of 60 liter/1.73 m2 or more with the various prescrip-
Several important adequacy issues currently remaintions and PTRs is shown in Figure 9. The proportion of
unsolved. The current standards of adequacy are basedpatients capable of achieving adequacy fell by 20% using
on the assumption that peritoneal and renal clearancethe CCr of 60 liter/1.73 m2 or more criterion of adequacy.
are equivalent. If prospective, controlled clinical studiesFigure 10 illustrates the predicted maximum BSA for
were to show that the renal contribution is significantlypatients undergoing PD with different modalities and
better than peritoneal clearance, it is reasonable to as-with various PTRs in order to achieve a weekly CCr of
sume that the goals of adequacy should be higher for60 liter/1.73 m2 or more. A strong correlation between
anuric patients. The importance of urea or creatinine asdialysis solution volume and the proportion of patients
markers of clinical outcome in ESRD is also unclear.achieving adequacy with either criterion was observed
(Fig. 11). The correlation between clinical outcome and PD dose
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Fig. 6. Predicted proportion of male patients
capable of achieving a weekly Kpt/V of 2.1 or
more according to modality of therapy and
peritoneal transport rates. Values above the
bars denote the percentage of patients achiev-
ing Kpt/V for that specific PTR group and
prescription. The total percentage refers to
the total proportion of male patients predicted
to attain a Kpt/V 5 2.1 with that particular
prescription. Symbols are: (h) low; ( ) low-
average; ( ) high-average; (j) high.
Fig. 7. Predicted proportion of female pa-
tients capable of achieving a weekly Kpt/V of
2.1 or more according to modality of therapy
and peritoneal transport rates. Symbols are:
(h) low; ( ) low-average; ( ) high-average;
(j) high.
Fig. 8. Predicted proportion of all patients
capable of achieving a weekly Kpt/V of 2.1 or
more according to modality of therapy and
peritoneal transport rates. Symbols are: (h)
low; ( ) low-average; ( ) high-average; (j)
high.
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Fig. 9. Predicted proportion of patients capa-
ble of achieving a weekly CCr of 60 liter/1.73
m2 or more according to modality of therapy
and peritoneal transport rates. Symbols are:
(h) low; ( ) low-average; ( ) high-average;
(j) high.
Fig. 10. Predicted maximum body surface
area (BSA) for patients undergoing different
modalities according to peritoneal transport
rate in order to achieve a CCr of 60 liter/
1.73 m2 or more. Symbols are: (h) low; ( )
low-average; ( ) high-average; (j) high.
suggests that urea indices have more favorable results
than creatinine [4, 5]. Trying to satisfy the creatinine
clearance goals, however, is recommended because that
effort will guarantee a higher total dialysis dose. It is
much easier to satisfy the urea clearance adequacy goals
than the creatinine, except in very high transporters.
Finally, several studies have strongly suggested that
high peritoneal transport is associated with inferior prog-
nosis [19–24]. If faster transport is indeed a marker of
poor clinical outcome, justifying transfer of those pa-
tients to HD, the proportion of patients able to dialyze
adequately with PD would diminish significantly. Thus,
it is important to further characterize the potential etiol-
ogy of rapid peritoneal transport and to develop effective
means to prevent and treat protein malnutrition, which
Fig. 11. Relationship between total daily volume of dialysis solution is common among high transporters.
used and degree of adequacy achieved according to the two adequacy The higher suggested standards of PD therapy andcriteria used: (j) weekly Kpt/Vurea 5 2.1 and (h) CCr 5 60 liter/1.73 m2.
Solid lines without symbols represent linear regressions. the aforementioned unresolved adequacy issues favor
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clinical practices for maximizing peritoneal dialysis clearances.the use of APD. As RRF is lost, most patients require
Perit Dial Int 16(Suppl 5):S448–S456, 1996
higher doses of therapy not achievable with CAPD. The 9. Burkart JM, Schreiber M, Korbet SM, Churchill DN, Ham-
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approach to adequacy of peritoneal dialysis. Perit Dial Int 16:457–tion of APD modalities [25]. The clinical evidence accu- 470, 1996
mulated during the last decade has stimulated the search 10. Rocco MV: Body surface area limitations in achieving adequate
therapy in peritoneal dialysis patients. Perit Dial Int 16:617–622,for more effective modalities of therapy characterized
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